Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 1614
116th Congress(2019-2020)
John S. McCain Opioid Addiction Prevention Act
Introduced
Introduced
Introduced in House on Mar 7, 2019
Overview
Text
Introduced in House 
Mar 7, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Mar 7, 2019)
Mar 7, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 1614 (Introduced-in-House)


116th CONGRESS
1st Session
H. R. 1614


To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

March 7, 2019

Mr. Katko (for himself and Mr. Suozzi) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “John S. McCain Opioid Addiction Prevention Act”.

SEC. 2. Registration requirements for prescribers.

Section 303 of the Controlled Substances Act (21 U.S.C. 823) is amended by adding at the end the following:

“(l) (1) Creating obligations for practitioners, only as described herein, the Attorney General shall not register, or renew the registration of, a practitioner under subsection (f) who is licensed under State law to prescribe controlled substances in schedule II, III, or IV, unless the practitioner submits to the Attorney General, for each such registration or renewal request, a certification that the practitioner, during the applicable registration period, will not prescribe any schedule II, III, or IV opioid, other than an opioid prescription described in paragraph (3), for the initial treatment of acute pain in an amount in excess of the lesser of—

“(A) a 7-day supply (for which no refill is available); or

“(B) an opioid prescription limit established under State law.

“(2) In this subsection, the term ‘acute pain’—

“(A) means pain with abrupt onset and caused by an injury or other process that is not ongoing; and

“(B) does not include—

“(i) chronic pain;

“(ii) pain being treated as part of cancer care;

“(iii) hospice or other end-of-life care; or

“(iv) pain being treated as part of palliative care.

“(3) An opioid prescription described in this paragraph is a prescription—

“(A) for a schedule II, III, or IV opioid drug approved by the Food and Drug Administration for an indication for the treatment of addiction; and

“(B) that is for the treatment of addiction.”.